Prospects improve for long-lasting flu vaccine

Rationing the flu vaccine.

In October 2004, the CDC announced that Chiron Corporation, chief supplier of inactivated influenza vaccine for the United States for the 2004–2005 flu season, would not be providing the 50 million vaccinations it had promised—half of the anticipated 90–100 million doses from all sources projected for the flu season. The resultant shortage set off a firestorm of concern. Well known to health ca...

Vaccine Confers Long-Lasting Protection A Nonadjuvanted Polypeptide Nanoparticle

The quest for a H1N1 flu vaccine.

Strategy for approving a universal flu vaccine

Prospects for an AIDS vaccine.

Acquired immunodeficiency syndrome (AIDS) was first identified at the end of 1981.1 In 1983, the causative virus, human immunodeficiency virus (HIV-1), was identified2, almost certainly having entered humans from a reservoir in chimpanzees, possibly on several occasions.3 Since 1981 the virus has spread to cause possibly the most serious epidemic infection in human history. The virus has divers...